Oct 31, 2013, 02.24 PM IST
Revenues, too, grew 16.5 percent higher-than-expected to Rs 3,357.4 crore during second quarter from Rs 2,880.9 crore in a year ago period.
Like this story, share it with millions of investors on M3
Dr Reddy's Q2 beats estimates, net soars 69.4% to Rs 690 cr
Revenues, too, grew 16.5 percent higher-than-expected to Rs 3,357.4 crore during second quarter from Rs 2,880.9 crore in a year ago period.
Like this story, share it with millions of investors on M3
Dr Reddy's Q2 beats estimates, net soars 69.4% to Rs 690 cr
Revenues, too, grew 16.5 percent higher-than-expected to Rs 3,357.4 crore during second quarter from Rs 2,880.9 crore in a year ago period.
Hyderabad-based Dr Reddy's Laboratories surpassed analysts' expectations with consolidated net profit growing 69.4 percent year-on-year to Rs 690.3 crore in three-month period ended September 2013.
Revenues also grew 16.5 percent higher-than-expected to Rs 3,357.4 crore during second quarter from Rs 2,880.9 crore in a year ago period.
According to a CNBC-TV18 poll, analysts on an average had expected the healthcare company to report net profit of Rs 498 crore on revenues of Rs 3,340 crore for the quarter.
Anda sedang membaca artikel tentang
Dr Reddy's Q2 beats estimates, net soars 69.4% to Rs 690 cr
Dengan url
http://sehatgayahidup.blogspot.com/2013/10/dr-reddys-q2-beats-estimates-net-soars.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Dr Reddy's Q2 beats estimates, net soars 69.4% to Rs 690 cr
namun jangan lupa untuk meletakkan link
Dr Reddy's Q2 beats estimates, net soars 69.4% to Rs 690 cr
sebagai sumbernya
0 komentar:
Posting Komentar